OSLO--(BUSINESS WIRE)--Regulatory News: On 29 October 2010 the general assembly in DiaGenic ASA (OSE:DIAG) resolved a private placement of 140 million new shares and a subsequent offering of up to 60 million new shares, both at a subscription price of NOK 0.50 per share. The share capital increase from the private placement of 140 million new shares has now been registered with the Norwegian Register of Business Enterprises. Following the registration, DiaGenic’s share capital is NOK 10,511,826, divided into 210,236,520 shares, each with a nominal value of NOK 0.05. The Articles of Association of the Company have been revised accordingly. Please find attached updated company certificate.
